An antibody-based microarray assay for small RNA detection by Hu, Zonglin et al.
An antibody-based microarray assay for small
RNA detection
Zonglin Hu, Aixia Zhang
1, Gisela Storz
1, Susan Gottesman
2 and Stephen H. Leppla*
Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases,
1Cell Biology and
Metabolism Branch,NationalInstituteof Child Healthand HumanDevelopment and
2Laboratoryof Molecular Biology,
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Received January 14, 2006; Accepted March 16, 2006
ABSTRACT
Detection of RNAs on microarrays is rapidly becom-
ing a standard approach for molecular biologists.
However, current methods frequently discriminate
against structured and/or small RNA species. Here
we present an approach that bypasses these prob-
lems. Unmodified RNA is hybridized directly to
DNA microarrays and detected with the high-affinity,
nucleotide sequence-independent, DNA/RNA
hybrid-specific mouse monoclonal antibody S9.6.
Subsequent reactions with a fluorescently-labeled
anti-mouse IgG antibody or biotin-labeled anti-
mouse IgG together with fluorescently labeled strep-
tavidin produces a signal that can be measured in a
standard microarray scanner. The antibody-based
method was able to detect low abundance small
RNAs of Escherichia coli much more efficiently than
the commonly-used cDNA-based method. A specific
small RNA was detected in amounts of 0.25 fmol
(i.e. concentration of 10 pM in a 25 ml reaction). The
method is an efficient, robust and inexpensive
technique that allows quantitative analysis of gene
expression and does not discriminate against
short or structured RNAs.
INTRODUCTION
DNA microarrays are powerful tools that measure the expres-
sion of tens of thousands of genes simultaneously (1,2).
Microarray systems have been widely used in almost every
area of biological research, from basic research to clinical
diagnostics (3). One of the most challenging aspects in the
use of microarrays to analyze gene expression is the prepara-
tion and labeling of the RNA transcripts. Frequently, only
small amounts of the biological samples are available, making
capturing an accurate representation of labile RNAs difﬁcult.
Even more challenging can be detecting small, non-coding
RNAs. These RNAs have been found recently to have unanti-
cipated regulatory roles, and the study of such RNAs has taken
on new importance (4,5). Many of these RNAs are very small,
most being 40–300 nt in bacteria. MicroRNAs, an abundant
class of small, non-coding RNA in eukaryotes, are even smal-
ler, generally only 22 nt (4,6,7). They may be expressed under
restricted conditions, can be short-lived, and may have com-
plex secondary structures. Their small size and structure make
them particularly poor substrates for cDNA synthesis using
random primers; direct labeling of the RNA by ligation or
chemical modiﬁcation may also be impeded by their structure.
In prior work from this laboratory, a novel microarray
protocol was used to identify a number of previously unknown
small Escherichia coli RNAs (sRNAs) that bind the
RNA chaperone protein Hfq (8). RNA isolated after co-
immunoprecipitation with Hfq was hybridized to microarrays
and the resulting hybrids were detected with an antibody spe-
ciﬁc to DNA/RNA hybrids. The antibody was from the Hybrid
Capture ExpressArray Kit obtained from Digene Corporation
(Gaithersburg, MD). Unfortunately, this kit is no longer being
marketed. Because this approach showed considerable prom-
ise for the discovery and expression analysis of sRNAs, we
attempted to develop a similar antibody-based strategy for
detection of DNA/RNA hybrids. Here we describe an
antibody-based microarray assay for DNA/RNA detection
and gene expression analysis that provides simple, rapid,
highly sensitive and reproducible quantitative detection of
gene expression.
MATERIALS AND METHODS
Total RNA
Total E.coli RNA was purchased from Ambion (made from
DH5a cultures harvested during the log phase of growth at an
A600 of 0.8, catalog no. 7940, Austin, TX) or isolated from
exponentially-growing cultures of MG1655 (A600 of 0.4) left
untreated or exposed to 0.2 mM hydrogen peroxide for 5 min
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extraction method as described previously (9). For analysis
using Affymetrix arrays, the total RNA isolated from MC4100
cells was treated with Turbo DNase (Ambion) to remove
residual chromosomal DNA. The 16S and 23S ribosomal
RNAs (rRNAs) were also removed from one sample using
MICROBExpress Bacterial mRNA Enrichment Kit (Ambion).
Total RNA and rRNA-depleted RNA were then fragmented
by incubating in 1· NEB buffer for T4 polynucleotide kinase
(70 mM Tris–HCl, 10 mM MgCl2, 5 mM DTT, pH 7.6, New
England Biolabs, Ipswich, MA) at 95 C for 30 min.
Co-immunoprecipated RNA
RNA that co-immunoprecipitates with Hfq was prepared as
described previously with the following modiﬁcations (8).
Cell extracts were made from MC4100 cells grown overnight
in Luria–Bertani medium at 37 C, and immunoprecipitations
were carried out using 20 ml of Hfq antiserum (10), 24 mg of
protein A–Sepharose (Amersham Biosciences, Piscataway,
NJ) and 200 ml of cell extract per immunoprecipitation reac-
tion. Immunoprecipitated RNA was isolated from protein
A–Sepharose beads by extraction with phenol:chloroform:
isoamyl alcohol (50:50:1), followed by ethanol precipitation.
OxyS RNA
Fragments carrying a T7 promoter and the oxyS coding
sequence were ampliﬁed from plasmid pGSO100 (11) by
PCR using primers (50-CTT GAA TTC TAA TAC GAC
TCA CTA TAG GGA AAC GGA GCG GCA CC and 50-
TAC AAG CTT GCG GAT CCT GGA GAT CCG CAA
AAG TT). OxyS RNA then was synthesized by in vitro tran-
scription with T7 RNA polymerase (New England Biolabs).
Antibodies
The mouse monoclonal antibody S9.6 directed to DNA/RNA
hybrids (12) was initially provided by Dr James G. Lazar
(Marligen Biosciences, Inc., Ijamsville, MD), and later was
produced from the hybridoma cell line purchased from ATCC
(cell line ATCC HB-8730; Manassas, VA). Polyclonal anti-
bodies to DNA/RNA hybrids (13,14) that were kindly
provided by Dr B. David Stollar (Tufts University) included
goat 4 A-E puriﬁed IgG, goat 4H antiserum, and sheep 4B
antiserum.
Secondary antibody detection reagents included Cy3-
labeled goat anti-mouse IgG (catalog no. 078-18-061; KPL,
Gaithersburg, MD), Cy3-labeled rabbit anti-goat IgG (catalog
no. 81-1615; Zymed Laboratories, San Francisco, CA), and
biotin-labeled rabbit anti-mouse IgG (Zymed catalog no.
81-6740). Detection was carried out using streptavidin
R-phycoerythrin (SAPE) conjugate (catalog no. S-866; Mole-
cular Probes, Eugene, OR) and Streptavidin Alexa Fluor 633
conjugate (catalog no. S-21375, Molecular Probes).
Glass slide microarray design and fabrication
Amino-modiﬁed (Amino-C6) oligodeoxynucleotides (Supple-
mentary Table S1) were synthesized at 0.2 mmol scale by
Operon Biotechnologies, Inc. (Germantown, MD). Except
for the yeast histidine-tRNA oligonucleotides, all oligonuc-
leotides used here correspond to sequences of E.coli rRNA or
small regulatory RNAs that have been studied previously in
this laboratory (8). Oligonucleotides were dissolved in
phosphate-buffered saline (PBS) (1.7 mM KH2PO4, 5.2 mM
NaHPO4 and 150 mM NaCl) and printed onto epoxy-coated
slides (catalog no. 40042; Corning, Acton, MA) at 25 pmol per
0.5 mm diameter spot using an OmniGrid printer
(GeneMachine, Ann Arbor, MI). Four identical blocks were
printed on each slide, and in each block every oligonucleotide
was printed twice, side by side, arranged in 6 rows and
16 columns. Prior to RNA hybridization, slides were treated
with 5· SSC, 1% BSA, 0.2% SDS at 45 C for 60 min. The
slides were then washed twice with water, twice with isopro-
panol, and air dried.
Glass slide microarray hybridization with
antibody staining
Various amounts of RNA were added to 50 ml of hybridization
buffer (HB) (100 mM MES, pH 6.6, 1 M NaCl, 20 mM EDTA
and 0.01% Tween 20) supplemented with 0.1 mg/ml herring
sperm DNA and 0.5 mg/ml gelatin, heated to 98 C for 5 min
and placed onto the slide. The RNA solution was conﬁned
to an area of 25 · 44 mm by use of an elevated coverslip
(LifterSlip, 25X44I-2-4775; Erie Scientiﬁc, Portsmouth, NH),
and the slide was incubated at 45 C in a microarray hybrid-
ization chamber (catalog no. 2551, Corning) for 16 h. The
coverslip was removed and the array washed several times
by placing it into 50 ml conical tubes containing 40 ml of
non-stringent wash buffer (NSWB) [6· SSPE (20· SSPE: 3.6
M NaCl, 0.2 M NaH2PO4, 0.02 M EDTA, pH 7.4), 0.01%
Tween 20]. The slide was placed into a 50 ml conical tube
containing 40 ml of stringent wash buffer (SWB) (100 mM
MES, pH 6.6, 25 mM NaCl, 0.01% Tween 20) at 45 C for
15 min with occasional shaking, followed by another 15 min
wash in SWB at 45 C in a new tube. All subsequent operations
were performed at room temperature. The array slide was
further washed in a 50 ml conical tube containing 40 ml of
NSWB and brieﬂy air-dried. Mouse monoclonal antibody (or
other anti-DNA/RNA hybrid primary antibody) was diluted in
PBS with 0.05% Tween 20 (PBST) containing 2 mg/ml gelatin
(catalog no. 170-6537; BioRad, Richmond, CA) and applied
to the slide under a new LifterSlip. After 1 h incubation in a
humidiﬁed box, the slide was washed successively in four
50 ml tubes, each containing 40 ml PBST. Slides were then
incubated with a ﬂuorescently-labeled secondary antibody (or
other combinations of secondary detection reagents) for 1 h as
above. Finally, the slides were washed ﬁve times in 50 ml
tubes containing 40 ml PBST, centrifuged 5 min at 100 g to
remove all liquid, and scanned in either an Axon GenePix
4000B or 4100A ﬂuorescence scanner, using ﬁlters appropri-
ate for the particular ﬂuorescent conjugate. Data were collec-
ted and analyzed using GenePix Pro 6.0 software.
Glass slide microarray hybridization of labeled cDNA
cDNA synthesis and ﬂuorescent labeling was performed by
combining DNase-treated total RNA (8 mgi n1 5ml) with
1 ml random hexamer (catalog no. 27-2166-01; Amersham
Pharmacia). The mixture was heated at 70 C for 5 min and
cooled on ice. RT–PCR was done by adding 10 ml Master Mix
B (100 mM DTT, 100 mM dATP, 100 mM dCTP, 100 mM
dGTP and 100 mM dTTP), 2 ml dUTP-Cy3 (catalog
no. PA53022; Amersham Pharmacia), 1.5 ml Superscript II
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90 min. The reaction was terminated by adding 10 mlo f1M
NaOH andincubating at70 Cfor15min,followed byaddition
of 10 ml of 1 M HCl. The sample was transferred to a Vivaspin
500 tube with 10K cutoff (catalog no. VS0122; Vivascience)
with 400 ml TE, and centrifuged at 9100 g for 8 min. The
retentate was washed 5–6 times in a fresh Vivaspin 500 to
assure removal of nucleotides and byproducts. The retained
sample was recovered in a total volume of 22 ml. The
Cy3-labeled cDNA was mixed with 3 ml herring sperm
DNA (10 mg/ml) and 25 ml hybridization solution (50% form-
amide, 10· SSC, 0.4% SDS). The mixtures were heated
to 98 C for 5 min and placed onto the slide under a coverslip.
The slide was incubated at 45 C in a Corning microarray
hybridization chamber for 16 h. The slide was washed with
40 ml of 1· SSC, 0.05% SDS in a 50 ml tube twice for 5 min,
followed by washing twice with 0.1· SSC. The slide was
centrifuged at 600 r.p.m. for 5 min to dry, scanned in either
anAxonGenePix 4000Bor4100A ﬂuorescencescanner,using
ﬁlters appropriate for the particular ﬂuorescent conjugate.
Data were collected and analyzed using GenePix Pro 6.0
software.
Affymetrix microarray hybridization and antibody
staining
Microarray analysis was carried out by hybridizing RNA
directly to the Affymetrix E.coli Sense Genome Arrays
(P/N 510051; Affymetrix, Santa Clara, CA) according to
the Affymetrix GeneChip  Expression Analysis Technical
Manual (www.Affymetrix.com) with some modiﬁcations.
This Sense Genome Array contains 15 25mer probes in
each gene, as well as across intergenic regions, designed to
hybridize directly to mRNAs. The RNA samples (2 mg for
co-immunoprecipitated RNA and 20 mg for total RNA or
rRNA-depleted RNA) were added to HB supplemented
with 0.1 mg/ml herring sperm DNA, 0.5 mg/ml BSA and
50 pM of the control biotin-labeled oligonucleotide B2 in
200 ml total volume, heated to 99 C for 5 min and then incub-
ated at 45 C for an additional 5 min before being placed in
the microarray cartridge. Hybridization was carried out at
45 C for 16 h on a rotary mixer at 60 r.p.m. Following hybrid-
ization, the sample solution was removed and the array was
washed in the Affymetrix Fluidics station as recommended in
the technical manual. Hybridization was detected using the
RNA:DNA mouse monoclonal antibody described above. The
antibody was diluted to 0.02 mg/ml in staining buffer (SB)
(100 mM MES, pH 6.6, 1 M NaCl and 0.05% Tween 20) with
2 mg/ml BSA (600 ml total volume), loaded on the array and
incubated at 25 C for 60 min. After 10 wash cycles in NSWB,
the array was incubated with 0.02 mg/ml biotin-labeled rabbit
anti-mouse IgG and 0.4 mg/ml rabbit IgG (Sigma, St Louis,
MO) in SB with 2 mg/ml BSA at 25 C for 60 min (600 ml total
volume). After another 10 wash cycles in NSWB, the arrays
were incubated with 10 mg/ml streptavidin R-phycoerythrin
in SB with 2 mg/ml BSA at 25 C for 60 min (600 ml total
volume). After a third set of 10 wash cycles in NSWB, the
arrays were scanned in an Affymetrix laser scanner
(at 570 nm with a resolution of 3 mm). Data were collected
and analyzed using Affymetrix GeneChip Operations Soft-
ware (GCOS 1.4).
OptimizationofconditionsforuseofantibodiesforRNA
detection
In preliminary experiments not detailed here, the antibody
reagents were titrated to determine the optimum concentra-
tions needed to achieve high sensitivity while maintaining
speciﬁcity. Most experiments using the glass slide arrays
employed two-layer sandwiches: mouse monoclonal antibody
S9.6 followed by Cy3-labeled anti-mouse IgG. Although the
abundant 16S and 23S rRNAs in the total E.coli RNA sample
could be detected with these arrays using as little as 10 pM of
monoclonal S9.6 (data not shown), we wished to ﬁnd condi-
tions suitable for detection of the less abundant sRNAs. There-
fore, we used three sRNAs in titration experiments. These
showed that ﬂuorescence intensities increased when higher
concentrations of S9.6 were used in reactions followed by
reaction with Cy3-labeled anti-mouse IgG (data not shown).
Aconcentration ofabout 2mg/mlS9.6was optimum.Asimilar
dilution series was used to select an optimum concentration
of the Cy3-labeled anti-mouse antibody (Supplementary
Figure S1). Based on these data, we selected 1–2 mg/ml of
the Cy3-labeled antibody as optimum.
Because a stronger signal might be achieved through the
ampliﬁcation that occurs with the use of a three-layer sand-
wich, we compared the two-layer sandwich protocol to ones
thatusedantibody S9.6,followedbybiotin-labeled anti-mouse
IgG, and ﬁnally streptavidin conjugates of either Alexa Fluor
633 or R-phycoerthryin (Supplementary Table S2). Neither of
thealternative,morecomplexprotocolswasclearlysuperiorto
the two-layer procedure. However, a three-layer sandwich was
used for the high density Affymetrix arrays to accommodate
the standard settings for the Affymetrix ﬂuidics station.
RESULTS AND DISCUSSION
Identification of antibodies specific to DNA/RNA
hybrids
This work began as an attempt to extend a technique that
successfully identiﬁed small E.coli RNAs using antibody
detection of DNA/RNA hybrids on microarrays (8). Unfortu-
nately, the Digene kit from which the antibody was obtained is
no longer available. Although details are incomplete, the
Digene kitappearedtouseagoatpolyclonalantiserumspeciﬁc
to RNA/DNA hybrids. In order to develop a comparable
method, we sought other sources of antibodies having this
speciﬁcity.Polyclonalsheepand goatantibodiesraised against
synthetic homopolymer hybrids (13) were kindly provided by
David Stollar. We also became aware of a mouse hybridoma
cell line, S9.6, which was developed in 1986 at Miles Labor-
atories (12) and is now available from ATCC. This hybridoma
was produced by immunization with a duplex produced by
RNA polymerase transcription of the FX174 bacteriophage
single-stranded DNA genome. The S9.6 monoclonal antibody
was shown to bind to DNA/RNA hybrids in a largely
nucleotide sequence-independent manner and with a Kd of
1.2 · 10
 11 M. In spite of the unique properties of this anti-
body, it appears to have been rarely used, with the last reported
use being in 1992 (15).
Initial tests with the polyclonal goat and sheep antisera and
the monoclonal S9.6 antibody on spotted arrays suggested that
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with the S9.6 monoclonal antibody. Because of these results,
and because of the obvious advantages of monoclonal anti-
bodies, no further effort was made to characterize or optimize
the polyclonal antisera. All subsequent work used the S9.6
antibody.
ComparisonofmonoclonalantibodyandcDNAmethods
for RNA detection
To characterize the antibodies described above, we con-
structed small spotted microarrays with oligodeoxynucle-
otide probes for the sense and/or anti-sense strands of
small, non-coding RNAs, mRNAs, and non-translated struc-
tural RNAs (rRNAs) (Supplementary Table S1). The sRNAs
chosen were well characterized as being expressed either
constitutively during exponential and/or stationary phase or
in response to various stresses (4,8). The glass microscope
slides were printed with four identical blocks, with each
oligonucleotide deposited as adjacent duplicate spots in
each block.
Two types of E.coli RNA preparations were hybridized
to the microarrays. One was a commercial sample of total
E.coli RNA. The other samples were isolated from bacteria
we grew either with (induced) or without (uninduced) expos-
ure to hydrogen peroxide, which is known to induce the OxyS
sRNA (16). For all RNA samples, detection speciﬁcity and
sensitivity using a conventional cDNA method was compared
with that using the monoclonal antibody method (both
methods are described in Materials and Methods). The results
were similar for both types of RNA. The array signals for
one set of experiments, comparing the performance of the anti-
body method with that of the traditional cDNA method
for detection of RNAs in the commercial total RNA sample
are shown in Figure 1; the quantitative results for selected
RNAs are summarized in Table 1. In the table, the signal
for the incorrect strand was subtracted from the signal
for the correct strand probe. On average, the incorrect
strand gave signals of 30–100 U, which can be taken as back-
ground, while the correct strand gave signals of 100–8000
(Table 1).
The advantage of the antibody approach was evident when
detection of small, non-coding RNAs was considered. All
eight sRNAs were detected at levels well above the back-
ground by the antibody method but only two were detected
by the cDNA method. In contrast, both methods had a similar
ability to detect mRNAs. Thus, under the conditions used here,
sRNAs are more effectively detected using the antibody
method.
Sensitivity limits and probe length dependence for
antibody detection of RNAs
The commercial RNA sample contained very small amounts
of the OxyS sRNA (Figure 1 and Table 1). This allowed us to
examine the limits of detection by adding to this RNA sample
various known amounts of in vitro synthesized OxyS RNA.
The results are summarized in Supplementary Figure S2. As
expected, signal intensities increased as OxyS RNA amounts
increased, whereas the Spot42 signal did not change. With the
50mer probes, signiﬁcant signals were detectable for as little
as0.25fmol(10pMOxySRNAina25mlvolume).Inseparate
analyses, we serially diluted total RNA and found that rRNA
could also be detected in amounts of 0.25 fmol (data not
shown).
The microarray was designed to include OxyS oligonuc-
leotide probes of lengths of 15, 20, 25, 30 35 and 40 nt in
addition to the 50mers (the size for most probes in the array).
The signals for the OxyS RNA were highly dependent on
probe length, with signal detected only on probes of 20 nt
and longer, with the signal for 25mers being only 1/10 that
for 50mers (Supplementary Figure S2, data only for 25mer
and 50mer are shown). This may suggest that the epitope
recognized by the S9.6 antibody is a duplex of at least
15 nt. Furthermore, the high dependence on length suggests
that the simultaneous binding of both antigen-binding
sites of the antibody to either the same or neighboring
DNA:RNA duplexes may greatly increase the retention of
antibody on the array element. Finally, the array includes a
probe containing a single mismatch within the 25 nt OxyS
probe. The higher signal on the 25mer probe than on
the mismatch probe provides evidence for speciﬁcity of
detection.
Application of the antibody detection method to high
density microarrays
Many arrayexperimentsutilize commercially availablearrays.
E.coli arrays from Affymetrix, which contain oligonucleotide
probes on both strands of the intergenic regions, were used
in our previous experiments to detect small, non-coding
RNAs, both with direct biotin-labeling of the RNA (17) and
antibody detection using the Digene kit (8). As in the spotted
arrays described above, probes on different strands are needed
for RNA:DNA hybrid detection and cDNA detection. To com-
pare the results of our current method with the results we
previously obtained using the Digene kit, we probed the Affy-
metrix E.coli sense array with RNA isolated as before by
co-immunoprecipitation with Hfq (described in Materials
and Methods).
Overall, we obtained a low level of background with only a
limited number of probes showing high activity (93 annotated
mRNA and sRNA genes and 51 intergenic regions gave signal
considered signiﬁcant over background; data not shown). As
shown for the selected genes listed in Table 2, strong signals
were obtained for sRNAs shown previously to be present in
high levels in sRNA samples that co-immunoprecipitate with
Hfq (4.5S, DicF, DsrA, tmRNA and Spot42), while relatively
low levels of activity were detected for sRNAs shown
previously to be present in low levels in such samples (e.g.
6S RNA).
We also probed the Affymetrix sense array with total RNA
that was partially hydrolyzed as described in Materials and
Methods; preliminary experiments indicated that hydrolysis
of the RNA improved the signal. Two observations can be
made. First, the highest signals were detected for rRNA and
tRNAgenes(88outofthe100genesshowingthehighestsignal;
data not shown) even after removal of 16S and 23S rRNAs by
hybridization with rRNA-speciﬁc oligonucleotides attached to
magnetic beads. This observation is not surprising given the
abundance ofthese RNAs andthe sensitivityof the RNA:DNA
hybrid antibodies in detecting sRNAs. On the other hand, the
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the number detected using cDNAs made from the same RNA
(data not shown), although the detection was increased with
increasingamountsoftotalRNA,suggestingthattheRNAmay
be limiting. Second, information about possible Hfq targets
could be obtained by comparing the ratio of the signal for
the co-immunoprecipitation sample and the total RNA sample
(Table 2, last column). For sRNAs such as DicF, DsrA and
Spot42 which require Hfq for function, this ratio is >300. In
contrast, for sRNAs such as 4.5S RNA and tmRNA, the ratiois
lessthan1.0.Thiscomparisonisareﬁnementoverourprevious
globalsearch forHfq-binding RNAs (8) and should allow us to
identify still other sRNA candidates and their mRNA targets
(A. Zhang, G. Storz and S. Gottesman, unpublished data).
CONCLUSIONS AND PROSPECTS
In this report, we describe an antibody-based microarray assay
for DNA/RNA detection and gene expression analysis.
Polyclonal antibodies to DNA/RNA hybrids were described
a number of years ago (13) and their use on solid phases for
hybrid detection was suggested at that time (14). Antibodies of
this type do form the basis of successful viral diagnostics
marketed by Digene Corp, but are not available for other
uses, such as the one described here.
The mouse monoclonal antibody S9.6 (12) is speciﬁc for
DNA/RNA hybrids, and totally lacks reactivity to single or
double-stranded DNA or to rRNA. It was shown to have
100-fold lower afﬁnity to poly(A):poly(dT) hybrids than to
poly(I):poly(dC) hybrids, suggesting some degree of sequence
Figure 1. Comparison of antibody and cDNA methods for RNA detection. Spotted microarrays hybridized with 8 mg total E.coli RNA (Ambion) and
detected by the monoclonal antibody method (top block) and cDNA method (lower block). Note that for the antibody method, signals are expected for the
anti-sense spots (AS), while for the cDNA method, signals are expected for the sense spots (S). The grid at the bottom identifies the oligonucleotide in each
position,withthenamingconventionsandsequencesasshowninSupplementaryTableS1.Quantificationoffluorescentsignalsfromtwosucharraysispresentedin
Table 1.
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to interfere with the reactivity of S9.6 to DNA/RNA hybrids
formed from natural biological sequences.
The microarray method described here has a number of
advantages that warrant its further development and use. It
is simple, rapid, sensitive, quantitative, inexpensive, and uses
publicly-available reagents. Because it does not require amp-
liﬁcation or labeling of the RNA sample, it may not suffer the
variability reported to occur with some of the widely-used
microarray systems (18), and our results show that it will
be far more sensitive for the detection of small, non-coding
RNAs of the sort found in bacteria, and possibly also for
eukaryotic non-coding RNAs. Judging from the small group
of sRNAs and mRNAs tested on our spotted array, we estimate
that this method allows a better than 10-fold enrichment for
detection of sRNAs relative to messages compared to the
cDNA method. With the growing interest in sRNAs and
their roles in biology, approaches such as this should be
invaluable in deﬁning these RNAs using genome-wide
approaches, and in particular, densely tiled arrays having
probes covering all intergenic and antisense regions of a
genome.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank James G. Lazar of Marligen Biosciences, Inc. and
David Stollar of Tufts University for providing antibodies,
NIAID core facility staff including Tim Myers, Christopher
SchauppandGuojianJiangforslideprintingandscannerassis-
tance, Patricia Diaz of NIDCR for microarray instruction and
scanneruse,NadimMajdalani,YehoshuaGozesandDanaHsu
for advice and assistance. We thank David FitzGerald and
Karen Wassarman for their comments on the manuscript.
This research was supported by the Intramural Research
Programs of the NIH, NIAID, NICHD, and NCI, Center for
Cancer Research. Funding to pay the Open Access publication
charges for this article was provided by NIAID.
Conflict of interest statement. None declared.
REFERENCES
1. Schena,M., Shalon,D., Davis,R.W. and Brown,P.O. (1995) Quantitative
monitoring of gene expression patterns with a complementary DNA
microarray. Science, 270, 467–470.
2. Lockhart,D.J. and Winzeler,E.A. (2000) Genomics, gene expression and
DNA arrays. Nature, 405, 827–836.
3. Heller,M.J. (2002) DNA microarray technology: devices, systems, and
applications. Annu. Rev. Biomed. Eng., 4, 129–153.
Table 1. Quantification of RNAs detected by antibody and cDNA methods on spotted microarrays
Probe name Antibody-based method Specific signal AS-S cDNA-based method Specific signal S-AS
Fluorescent signal intensity
a ± SD Fluorescentsignal intensity
a ±S D
AS probe S probe S probe AS probe
sRNAs
DsrA 891 ± 209 309 ± 66 583 ± 219 88 ± 17 111 ± 5 -23 ± 18
Spot42 6015 ± 819 49 ± 10 5966 ± 819 565 ± 184 70 ± 12 494 ± 184
OxyS 558 ± 42 92 ± 5 466 ± 43 61 ± 5 64 ± 9 -3 ± 10
DicF 1182 ± 30 67 ± 11 1115 ± 32 96 ± 14 72 ± 1 24 ± 14
RybB 3709 ± 1027 163 ± 27 3547 ± 1027 50 ± 27 145 ± 45 -95 ± 52
OmrA 1781 ± 289 57 ± 12 1724 ± 289 74 ± 15 83 ± 8 -10 ± 17
RyiA 1615 ± 68 60 ± 5 1555 ± 69 320 ± 82 60 ± 10 260 ± 83
MicA 8044 ± 813 105 ± 28 7939 ± 813 106 ± 16 74 ± 13 32 ± 21
mRNAs
sodB 403 ± 6 46 ± 3 357 ± 7 497 ± 194 50 ± 8 448 ± 194
fhlA 217 ± 19 31 ± 11 186 ± 21 69 ± 10 29 ± 10 40 ± 14
ompA 633 ± 112 37 ± 1 596 ± 112 682 ± 208 34 ± 15 648 ± 209
galE 385 ± 112 72 ± 48 313 ± 122 177 ± 15 29 ± 10 149 ± 18
galK 152 ± 20 46 ± 9 107 ± 22 85 ± 12 24 ± 8 61 ± 15
ftsZ 641 ± 84 35 ± 8 607 ± 84 213 ± 52 16 ± 2 197 ± 52
hisG 162 ± 34 23 ± 3 139 ± 34 86 ± 31 20 ± 14 67 ± 34
hisI 115 ± 28 46 ± 2 69 ± 28 65 ± 23 17 ± 18 48 ± 29
aFluorescenceintensitiesforselectedprobesasmeasuredbythearrayscannerfortwodifferentslidesdoneondifferentdays(totalfourspots)ofwhichthatinFigure1is
one. AS, antisense; S, sense. Signals were averaged with SD without further correction for background. Instead, the signal of the opposite strand was taken as
background to calculate a specific signal value.
Table 2. Antibody detection of RNA hybridized to high density microarrays
Fluorescent signal intensity
sRNAs Total RNA—rRNA
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total, per mg
input RNA
4.5S 12977700 21249200 1324900 0.6
DicF 455 425 14404 300
DsrA 3963 415 32939 800
tmRNA 11023100 4059300 31055 0.08
Spot42 905 341 47028 1300
6S 13909800 6568700 2392 0.004
Total RNA was extracted from E.coli and half of the sample was depleted for
rRNA. Both samples were subsequently fragmented. RNA was also immuno-
precipitated from E.coli lysates with antisera to Hfq (IP). All samples were
hybridized to Affymetrix arrays and detected with the S9.6 monoclonal anti-
body.Signalintensitiesarereportedforthegeneasawhole(usually15probes)
after correction for the signal of the corresponding mismatch probe, as calcu-
lated by the Affymetrix software.
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